ResMed Inc. (RME)
Summary
RME Chart
Wall Street Lunch: AI Regulation Hopes Fade After Trump Calls AI Concerns A 'Hoax'
AI regulation odds have sharply declined after Trump dismissed AI takeover concerns during a public call with Nvidia (NVDA) CEO Jensen Huang. ResMed (RMD) was upgraded to Outperform by RBC Capital Markets, with a price target raised to $262, citing strong Q4 results and expected high-single-digit EPS growth.
Is This the Right Time to Retain Resmed Stock in Your Portfolio?
RMD's software portfolio optimization, mask innovation and solid financial health support growth, though macro pressures and competition pose risks.
The IRS Lets You Send Your RMD Straight to Charity and Skip the Tax Entirely. These 3 ETFs Replace the Income You Gave Away
A Qualified Charitable Distribution can wipe your RMD off your tax return entirely, but it also kills the income you were counting on. Three ETFs can rebuild that cash flow, and they each do it a completely different way.
ResMed Inc. (RME) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has ResMed Inc. ever had a stock split?
ResMed Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Michael J. Farrell CEO | XHAN Exchange | US7611521078 ISIN |
| US Country | 11,370 Employees | 20 Aug 2026 Last Dividend | 31 Aug 2010 Last Split | 2 Jun 1995 IPO Date |
Overview
ResMed Inc. is a pioneering company focused on developing, manufacturing, distributing, and marketing medical devices alongside cloud-based software applications tailored for the healthcare markets. With its operational base divided between Sleep and Respiratory Care, and Software as a Service (SaaS), ResMed is at the forefront of offering innovative solutions for managing respiratory disorders. The company's extensive product lineup and software solutions cater to both medical and consumer needs, aiming to improve patient outcomes through advanced technology and connectivity. Founded in 1989 and headquartered in San Diego, California, ResMed markets its products globally through a combination of direct sales forces and a network of distributors, targeting sleep clinics, home healthcare dealers, and hospitals.
Products and Services
- Technologies for Respiratory Disorders - ResMed offers an array of products for treating various respiratory disorders, including ventilation devices, diagnostic products, and mask systems for use in hospitals and homes. These products are complemented by headgear, accessories, and dental devices, integrating cutting-edge technology for both medical and consumer applications.
- Cloud-Based Software Informatics - The company's software solutions, such as AirView and myAir, facilitate remote monitoring and management of patient outcomes. AirView allows healthcare professionals to remotely monitor and adjust patients' device settings, while myAir, a personalized therapy management app, supports patients with sleep apnea through education, troubleshooting tools, and engagement strategies to improve compliance.
- U-Sleep Compliance Monitoring - U-Sleep is a solution designed to help home medical equipment (HME) providers streamline their sleep programs by efficiently monitoring patient compliance, an essential factor for successful therapy outcomes.
- Out-of-Hospital Software Solutions - ResMed provides various software solutions like Brightree, MatrixCare, HEALTHCAREfirst, and MEDIFOX DAN, catering to the business management and caregiving needs of HME providers, pharmacies, senior living facilities, skilled nursing facilities, and hospice organizations. These solutions include business management software, electronic health records, billing, coding services, and analytics, facilitating improved care delivery and operational efficiency.
Contact Information
